Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ).  This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff of these organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities.  Over 20 investments, typically of $250,000 - $500,000 were made from this fund.  A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund.   The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.  With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.  On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).  Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation).    Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets.  It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide.  They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.  The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes.  Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Uniseed

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

Yuuwa Capital

Nexgen Plants

Nexgen is an emerging plant trait company delivering non-GM solutions for a range of pathogens, production traits and consumer traits. Our solutions help agriculture-dependent communities around the world improve returns and respond rapidly to emerging opportunities and challenges.  The proprietary transformation technique is developing crops that are virus-resistant; fungal-resistant; salt-tolerant; high in anthocyanin content; and aromatic. These solutions are developing the next generation of globally valued crops for food, fibre, energy and ornamentation.

Nexgen Plants develops plants for future generations. It discovers and unlocks the genetic diversity of plants to develop products such as novel ingredients, food, medicines, and biomaterials. Moreover, it discovers plant healthcare solutions by combining expertise in biology and chemistry to protect crops from pests and diseases. The company’s INTtrait technology develops new varieties of plants for agriculture and new plant-based raw materials for other sectors. Nexgen Plants offers resilient crops and healthier plants with the help of INTtrait technology. Headquartered in St. Lucia, Australia, the company is privately held.

Enhancing seed and crop traits via biotechnology

Crop Biotech

Nexgen Plants Pty Limited

Lone Star Industrial Materials is a cultivation company that manufactures raw hemp materials. Its product portfolio consists of bast fiber, refined cellulose, and hemp hurd, seeds, hearts, fines and oil. Additionally, it offers retail products such as HempSorb, animal bedding, and hemp control socks. Hemp requires less land, improves nutritional health, is environmentally friendly, helps soil regeneration, grows in various climates, absorbs a great deal of CO2, is a rotational crop and reduces waste. Hemp is used in construction, insulation, bioplastics, and as hemp wood. The privately held company has developed an end-to-end supply chain from seed genetics to delivery.

Lone Star Industrial Materials

PLANTeDIT operates in the plant genome editing field to produce improved crop species through transformation technology and a CRISPR/Cas9 delivery system. It produces regulatory-free, consumer-oriented, DNA-free and sustainable genome edited crops and biopharmaceuticals. The company’s offering includes non-transgenic high oleic soya, which is produced by mutating the FAD2 gene, which eventually increases the oleic oil content in the soya bean. This product was developed through a collaboration between PLANTeDIT and ToolGen. The organization has also collaborated with RebelBio, University College Cork and IAPB. Headquartered in Cork, Ireland, PLANTeDIT is privately held.

PLANTEDIT

<div>
 
 Amforo is a biotech company that focuses on developing foods that are high in protein by enhancing the nutritional density of food and feed crops through the platform of technologies it has built. The company offers a family of feed and food crops, including primary ingredients for suppliers of plant-based meat and dairy alternatives. In addition, it is focused on developing a low-cost, plant-based source of protein for farmed seafood. Moreover, Amforo is pursuing approaches to enhance the nutritional profile of crops as well as their protein content, which entails optimizing amino acid profiles, modifying carbohydrates, and enhancing micronutrients.
 
</div>

Amfora

BioHeuris provides weed management solutions by combining synthetic biology and gene editing to develop herbicide resistant crops. Its offering includes Heurik, a technology platform that integrates rational design and directed evolution to identify mutations that confer herbicide tolerance, while Swap is the platform that introduces these mutations in crops using gene editing. The company cultivates soybeans, sorghum, rice, cotton, and alfalfa. It has partnered with Santa Rosa Semillas, Adecoagro, Gensus, GDM, Aceleradora Litoral, Tobin, Rotam, Asociación de Cooperativas Argentinas, Benson Hill, and Plant Science Center. Headquartered in Rosario, Argentina, BioHeuris is privately held with an office in the US.

BioHeuris

<div>
 
 Tropic Biosciences is a privately held developer of high-performing commercial varieties of tropical crops that promote cultivation efficiencies, improve sustainable environmental practices and enhance consumer health through its use of cutting-edge genetic editing technologies. Its GEiGS Technology combines gene editing and RNAi in a single platform that enables critical disease resistance and quality improvement traits. The technology caters to the banana production, row crops, livestock, and poultry industries. The company’s partners include Temasek, Agronomics, Polaris Founders Capital, and Excellence Through Stewardship. Headquartered in the UK, Tropical Biosciences has been featured in The Telegraph, Nature, Fast Company, and the Financial Times. 
 
</div>

Tropic Biosciences

Companies that develop or use biological, physical and chemical agents and techniques to provide protection and improve the quality of a seed. This includes the sale of seed coating, or seed enhancement products as methods to treat seeds.

Companies that redesign large clusters of genes and gene parts rather than modifying or engineering a single gene for improving the traits of a plant.

Companies that utilize genetic engineering tools and technologies to use existing and naturally present gene variants in a plant and the natural process of breeding such as inbreeding, and linebreeding to develop better traits for plants.

Companies that use transgenesis processes like tissue culturing to develop transgenic plants or seeds by inserting new genes into them from other plants or in certain instances other organisms like bacteria or even animals.

Companies that offer techniques such as epigenetics, RNA interference (RNAi) to temporarily block a specific gene that would trigger unwanted effect such as a disease on a plant.

Companies that develop a platform to insert, edit, or delete the DNA of a plant itself using approaches such as CRISPR-Cas 9, TALENs, and Zinc Fingers. These approaches help develop plant genes or seeds with traits such as disease-resistant, enhanced-performance, or improve yield.

Biotech solutions to produce crops that are sustainable and offer better traits

Offers customization of genes and traits as required by farmers

Uses AI/machine learning to facilitate their platform/biotech processes like gene editing

Nexgen Plants Pty Limited

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless